RMD
ResMed Inc
NYSE: RMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$213.81
+0.89% today
Updated 2026-04-30
Market cap
$30.87B
P/E ratio
20.96
P/S ratio
5.72x
EPS (TTM)
$10.11
Dividend yield
1.04%
52W range
$212 – $292
Volume
1.0M
ResMed Inc (RMD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.01B | $1.25B | $1.41B | $1.51B | $1.63B | $2.07B | $2.14B | $2.21B | $2.36B | $2.18B | $3.26B | $3.47B | $3.06B | $4.11B | $4.59B | $4.73B | $5.10B | $6.75B | $6.87B | $8.17B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $510.28M | $668.80M | $739.24M | $853.28M | $985.34M | $1.29B | $1.36B | $1.45B | $1.56B | $1.44B | $1.42B | $1.64B | $1.07B | $1.15B | $1.52B | $1.57B | $1.93B | $2.37B | $2.36B | $3.51B |
| Total liabilities | $269.07M | $320.82M | $324.23M | $392.78M | $338.86M | $338.19M | $530.24M | $600.21M | $602.71M | $596.95M | $1.56B | $1.51B | $1.00B | $2.04B | $2.09B | $1.84B | $1.74B | $2.62B | $2.01B | $2.21B |
| Current liabilities | $129.00M | $202.40M | $192.59M | $269.10M | $312.67M | $208.84M | $252.85M | $574.05M | $269.56M | $267.26M | $638.55M | $360.13M | $511.25M | $555.99M | $602.76M | $911.77M | $689.30M | $758.53M | $910.65M | $1.02B |
| Long-term debt | $116.21M | $87.65M | $93.79M | $94.19M | — | $100.00M | $250.78M | $769000.00 | $300.77M | $300.59M | $875.00M | $1.08B | $269.99M | $1.26B | $1.16B | $643.35M | $765.33M | $1.43B | $697.31M | $658.39M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $370.65M | $436.95M | $548.34M | $694.79M | $884.88M | $1.11B | $1.37B | $1.58B | $1.78B | $1.98B | $2.16B | $2.32B | $2.43B | $2.44B | $2.83B | $3.08B | $3.61B | $4.25B | $4.99B | $6.08B |
| Accounts receivable | $138.15M | $175.77M | $209.31M | $214.16M | $232.23M | $283.65M | $285.44M | $327.26M | $359.59M | $362.57M | $382.09M | $450.53M | $483.68M | $528.48M | $474.64M | $614.29M | $575.95M | $704.91M | $837.27M | $990.67M |
| Inventory | $116.19M | $157.20M | $158.25M | $157.43M | $185.64M | $200.78M | $174.35M | $145.85M | $165.42M | $246.86M | $224.46M | $268.32M | $268.70M | $349.64M | $416.92M | $457.03M | $743.91M | $998.01M | $822.25M | $927.71M |
| Goodwill | $195.61M | $206.78M | $234.65M | $213.17M | $198.63M | $235.49M | $256.21M | $274.83M | $289.31M | $264.26M | $1.06B | $1.06B | $1.07B | $1.86B | $1.89B | $1.93B | $1.94B | $2.77B | $2.84B | $3.05B |